Immune checkpoint inhibitor-related gastrointestinal toxicity in patients with malignancy involving the luminal gastrointestinal tract and its impact on cancer outcomes

BACKGROUND: Immune checkpoint inhibitors (ICI) are known to cause immune-related adverse events (irAE) with the gastrointestinal (GI) tract among the most affected. Our knowledge of GI irAE in patients with luminal GI malignancies is poor. We aimed to characterize the incidence, clinical features, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Kevin, Mathew, Antony, Abraham, Fiyinfoluwa, Amin, Rajan, Kono, Miho, Overman, Michael, Zhao, Dan, Khan, Anam, Khan, Muhammad A., Thomas, Anusha S., Wang, Yinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399574/
https://www.ncbi.nlm.nih.gov/pubmed/36061157
http://dx.doi.org/10.20524/aog.2022.0742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399574/
https://www.ncbi.nlm.nih.gov/pubmed/36061157
http://dx.doi.org/10.20524/aog.2022.0742

Ejemplares similares